Identification of a feasible, non-invasive tool to predict the presence of liver fibrosis or cirrhosis in patients with NAFLD/NASH in the Primary Care setting

Beth Haftoglou, RN BSN CGRN, Patricia Nagy CphT; Jacklyn Spates, APNP

Contact: Beth.Haftoglou@va.gov

To determine if the use of the FIB4 Score or the NAFLD Fibrosis Score, which predicts the presence of fibrosis by an analysis of lab values, would be feasible for use by primary care providers to identify patients who may be at risk for developing liver cirrhosis and subsequently Hepatocellular Carcinoma.

Leave a Reply

Your email address will not be published. Required fields are marked *